Japanese pharma giant Sumitomo Pharma just took a significant step toward rebooting brains ravaged by Parkinson’s disease using stem cells, as reported by Japan Times.

Sumitomo has announced that it has filed for Japanese regulatory approval for a potentially groundbreaking treatment that transplants lab-grown cells directly into the brains of Parkinson’s patients. iPS cells, or induced pluripotent stem cells, make this possible.

These are adult cells turned back into stem cells with all the potential of embryonic ones. A stem cell even an anti-abortion conservative could love. They’re then coaxed into becoming dopamine-producing brain cells, the type Parkinson’s slowly erases.

Japanese Pharma Giant Seeking Approval For Revolutionary Parkinson’s Stem Cell Therapy

Sumitomo says that thi

See Full Page